Patrick Weiss COO, Twist Bioscience

Twist Bioscience Corporation, in high-quality synthetic DNA using its silicon platform, announced the promotion of Patrick A. Weiss from SVP R&D and GM data storage to COO.

It also appointed of founder Bill Banyai, Ph.D., as SVP of advanced development and GM of storage and formerly COO.

Both executive appointments support Twist’s drive for commercial growth.

“Patrick has built the operational infrastructure at Twist from the beginning, transforming a complex manufacturing process into a robust commercial platform,” said Emily M. Leproust, Ph.D., CEO and co-founder. “Patrick’s prior experience leading a DNA synthesis company and driving toward profitability will be integral as we manufacture additional products and continue to expand our commercial reach into the future.”

Dr. Banyai is a co-founder and director of the company and together with Bill Peck, Ph.D., CTO of Twist Bioscience, developed the silicon-based DNA synthesis platform, including both the software and hardware infrastructure.

He led the integration of Genome Compiler, a company Twist acquired in April 2016, and has been responsible for all facilities expansion. He will maintain his board seat.

“Bill has been instrumental in building and operationalizing our silicon-based DNA synthesis platform as well as supporting the growth of the company,” continued Leproust. “We are thrilled to have Bill commit to lead our commercialization efforts in DNA storage full time, employing his passion to develop practical solutions to complex engineering problems.”